Bird Flu > Bird Flu News > Generex presents Ii-Key hybrids product development at Gene based Vaccines conference

Generex presents Ii-Key hybrids product development at Gene based Vaccines conference
Generex Biotechnology Corporation today announced presentations in respect of the technologies and development products of its wholly-owned subsidiary, Antigen Express, Inc. The presentations were made at the conference Gene based Vaccines: Optimizing Development and Delivery 2010 held September 13 and 14, 2010 in Vienna, Austria and at the Immunotherapeutics and Vaccine Summit held in Cambridge ...